Our catalog lists 56 products that may treat hypertension, pulmonary, drawn from FDA drug-class data. Each is independently rated; the current top-rated option is tyvaso dpi.
What is the best-rated treatment for hypertension, pulmonary?
By our independent rating, tyvaso dpi currently ranks highest for hypertension, pulmonary. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
Treatment associations are derived from FDA drug-class data (RxClass “may treat”). This is general reference, not medical advice — always consult a licensed professional.
FDA-sourced
New
Nitroglycerin sublingual tablets are stabilized sublingual compressed tablets that contain 0.3 mg, 0.4 mg, or 0.6 mg nitroglycerin; as well as lactose monohydrate, NF; glyceryl monostearate, NF; pregelatinized starch, NF; calcium stearate, NF powder; and silicon dioxide, colloidal, NF.